# Clinical Study of the Safety and Pharmacokinetics of the Drug Fluorothiazinone, a Concentrate for Solution Preparation for Infusion.

> **NCT07184606** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation** · enrollment: 70 (estimated)

## Conditions studied

- Safety and Pharmacokinetics

## Interventions

- **DRUG:** ¼ of the full (target) dose (solution, 5 ml)
- **DRUG:** ½ of the full (target) dose (solution, 10 ml)
- **DRUG:** full dose (solution, 20 ml)
- **DRUG:** 1 ½ of the full (target) dose (solution, 30 ml)
- **DRUG:** 2 full doses (solution, 40 ml)
- **DRUG:** course administration of the selected dose
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07184606
- **Lead sponsor:** Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07184606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07184606, "Clinical Study of the Safety and Pharmacokinetics of the Drug Fluorothiazinone, a Concentrate for Solution Preparation for Infusion.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07184606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*